Snake Envenomation in Domestic Animal Species in Australia

Reference work entry
Part of the Toxinology book series (TOXI)

Abstract

Snakebite is a significant animal health problem for domestic animals in Australia. Animalsare more frequently envenomed than humans, perhaps due to their innate hunting instincts. The Australian continent is home to many highly venomous snakes. The most common snake species responsible for animal envenomation are the tiger snake (Notechis scutatus) and eastern brown snake (Pseudonaja textilis). Notable, but less frequently reported snake species include the red bellied black snake (Pseudechis porphyriacus), taipan (Oxyruanus scutellatus) and death adders (Acanthophis sp.). There is significant geographic variation between regions of Australia and the venomous snake species that occur. Dogs and cats are the most frequently reported animal species requiring veterinary treatment for clinically significant envenoming, however horses and other animal species are occasionally envenomed. A range of clinical syndromes have been reported for envenomed animals and are dependent upon the snake species. Animals may present with generalized paralysis, myopathy, coagulation disorders or local bite site reactions. The chronology and severity of clinical signs appear to be related to total venom dose received, bodyweight and elapsed time. Death may occur rapidly following envenomation from some species of snakes, particularly in low bodyweight dogs. Veterinarians commonly diagnose snakebite by interpretation of clinical signs, and application of hematological, biochemical and coagulation tests. The principle treatments used by veterinarians are antivenom, hospitalization, supportive care, and respiratory support measures. Research to improve diagnostic efficiency, better understanding of cost-benefit of various treatment approaches are required to improve outcomes for animals and owners.

Keywords

Animal Antivenom Brown snake Cat Dog Horse Snakebite Tiger snake 

References

  1. Agrawal PN, Aggarwal AN, Gupta D, Behera D, Prabhakar S, Jindal SK. Management of respiratory failure in severe neuroparalytic snake envenomation. Neurol India. 2001;49:25–8.PubMedGoogle Scholar
  2. Anon. American Thoracic Society documents. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2011;184:388–416. 329pCrossRefGoogle Scholar
  3. Barber CM, Isbister GK, Hodgson WC. Solving the ‘Brown snake paradox’: in vitro characterisation of Australasian snake presynaptic neurotoxin activity. Toxicol Lett. 2012;210:318–23.PubMedCrossRefGoogle Scholar
  4. Barr SC. Clinical features therapy and epidemiology of tiger snake bite in dogs and cats. Aust Vet J. 1984;61(7):208–12.Google Scholar
  5. Bassett T. A study on the effects of tiger snake venom and antivenom on the clotting system of the dog. Master of Veterinary Science thesis, University of Melbourne. 2002.Google Scholar
  6. Berton DC. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev(10): CD006482. 2014. https://www.ncbi.nlm.nih.gov/pubmed/25354013.
  7. Best P. Snake envenomation of companion animals. Sydney Postgraduate Foundation in Veterinary Science; 1998, p. 231–48.Google Scholar
  8. Bhattacharya P, Chakraborty A. Neurotoxic snake bite with respiratory failure. Indian J Crit Care Med. 2007;11:161.CrossRefGoogle Scholar
  9. Biӧrck G. Chapter VI: Significance of myoglobin in clinical medicine and pathology. Acta Medica Scandinavica. 1949;133:47–62.Google Scholar
  10. Boyd JW. The mechanisms relating to increases in plasma enzymes and isoenzymes in diseases of animals. Vet Clin Pathol. 1983;12:9–24.PubMedCrossRefGoogle Scholar
  11. Boyd JW. Serum enzymes in the diagnosis of disease in man and animals. J Comp Pathol. 1988;98:381–404.PubMedCrossRefGoogle Scholar
  12. Broad AJ, Sutherland SK, Coulter AR. The lethality in mice of dangerous Australian and other snake venom. Toxicon. 1979;17:661–4.PubMedCrossRefGoogle Scholar
  13. Brown CVR, Rhee P, Chan L, Evans K, Demetriades D, Velmahos GC. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference? J Trauma Injury Infect Crit Care. 2004;56:1191–6.CrossRefGoogle Scholar
  14. Brunetto MA, Gomes MO, Andre MR, Teshima E, Goncalves KN, Pereira GT, Ferraudo AS, Carciofi AC. Effects of nutritional support on hospital outcome in dogs and cats. J Vet Emerg Crit Care. 2010;20:224–31.CrossRefGoogle Scholar
  15. Callens AJ, Bartges JW. Urinalysis. Vet Clin North Am Small Anim Pract. 2015;45:621–37.PubMedCrossRefGoogle Scholar
  16. Campbell CH. Venomous snake bite in papua and its treatment with tracheotomy, artificial respiration and antivenene. Trans R Soc Trop Med Hyg. 1964;58:263–73.PubMedCrossRefGoogle Scholar
  17. Casamento AJ, Isbister GK. Thrombotic microangiopathy in two tiger snake envenomations. Anaesth Intensive Care. 2011;39:1124–7.PubMedGoogle Scholar
  18. Church S, Forbes G. Detection of snake venom in horse urine and plasma – validation of the snake venom detection kit in horses, RIRDC Publication No. 11/007. Rural Industries Research and Development Corporation; 2011.Google Scholar
  19. Churchman A, O’Leary MA, Buckley NA, Page CB, Tankel A, Gavaghan C, Holdgate A, Brown SG, Isbister GK. Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11). Med J Aust. 2010;193:696–700.PubMedGoogle Scholar
  20. Condrea E. Chapter 13. Hemolytic effects of snake venoms. In: Lee C, editor. Snake venoms. Berlin: Springer; 1979.Google Scholar
  21. Cox JC, Moisidis AV, Shepherd JM, Drane DP, Jones SL. A novel format for a rapid sandwich EIA and its application to the identification of snake venoms. J Immunol Methods. 1992;146:213–8.PubMedCrossRefGoogle Scholar
  22. Cullimore A, Lester G, Swindells K. Tiger snake (Notechis scutatus) envenomation in a horse. Aust Vet J. 2013;91:381–4.PubMedCrossRefGoogle Scholar
  23. Estrada R, Herrera M, Segura Á, Araya J, Boschini C, Gutiérrez JM, León G. Intravenous administration of equine-derived whole IgG antivenom does not induce early adverse reactions in non-envenomed horses and cows. Biologicals. 2010;38:664–9.PubMedCrossRefGoogle Scholar
  24. Fawcett A, Shea G, Cutter SM. Black Whipsnake (Demansia papuensis species group) envenomation in a Jack Russell terrier. Aust Vet Practitioner. 2014;44:627–30.Google Scholar
  25. Fitzgerald WE. Snakebite in the horse. Aust Vet J. 1975;51:37–9.PubMedCrossRefGoogle Scholar
  26. Furneaux RW. Successful recovery in a dog from a common Brown Snake (Demansia textalis) bite. Aust Vet J. 1967;43:147–8.PubMedCrossRefGoogle Scholar
  27. Gordon RN. The sypmtoms, diagnosis and treatment of snake-bite in the dog. Aust Vet J. 1958;34:216–21.CrossRefGoogle Scholar
  28. Gulati A, Isbister GK, Duffull SB. Effect of Australian elapid venoms on blood coagulation: Australian Snakebite Project (ASP-17). Toxicon. 2013;61:94–104.PubMedCrossRefGoogle Scholar
  29. Hart AJ, Hodgson WC, O’Leary M, Isbister GK. Pharmacokinetics and pharmacodynamics of the myotoxic venom of Pseudechis australis (mulga snake) in the anesthetised rat. Clin Toxicol (Phila). 2014;52:604–10.CrossRefGoogle Scholar
  30. Hawdon GM, Winkel KD. Could this be snakebite? Aust Fam Physician. 1997;26:1386–91 , 1393–1384.PubMedGoogle Scholar
  31. Heller J, Bosward KL, Hodgson JL, Cole FL, Reid SWJ, Hodgson DR, Mellor DJ. Snake envenomation in dogs in New South Wales. Aust Vet J. 2005;83:286–92.PubMedCrossRefGoogle Scholar
  32. Heller J, Bosward KL, Hodgson DR, Pottie R. Anuric renal failure in a dog after red-bellied black snake (Pseudechis porphyriacus) envenomation. Aust Vet J. 2006;84:158–62.PubMedCrossRefGoogle Scholar
  33. Hill FW. Snake bite in dogs. Aust Vet J. 1979;55:82–5.PubMedCrossRefGoogle Scholar
  34. Hill FWG, Campbell T. Snake Bite in Cats. Aust Vet J. 1978;54:437–9.PubMedCrossRefGoogle Scholar
  35. Holloway SA, Parry BW. Observations on blood coagulation after snakebite in dogs and cats. Aust Vet J. 1989;66(11):364–6.Google Scholar
  36. Hopper K, Powell LL. Basics of mechanical ventilation for dogs and cats. Vet Clin North Am Small Anim Pract. 2013;43:955–69.PubMedCrossRefGoogle Scholar
  37. Hopper K, Beck C, Slocombe R. Megaoesophagus in adult dogs secondary to Australian tiger snake envenomation. Aust Vet J. 2001;79:672–5.PubMedCrossRefGoogle Scholar
  38. Hopper K, Haskins SC, Kass PH, Rezende ML, Aldrich J. Indications, management, and outcome of long-term positive-pressure ventilation in dogs and cats: 148 cases (1990–2001). J Am Vet Med Assoc. 2007;230:64–75.PubMedCrossRefGoogle Scholar
  39. Indrawirawan Y, Sheridan G, McAlees T. Clinical features of Mainland tiger and Eastern brown snake envenomation in dogs and cats in Melbourne. Aust Vet Practitioner. 2014;44:704–12.Google Scholar
  40. Ireland G, Brown SG, Buckley N, Stormer J, Currie B, White J, Spain D, Isbister GK. Changes in serial laboratory test results in snakebite patients: when can we safely exclude envenoming? Med J Aust. 2010;193:285–90.PubMedGoogle Scholar
  41. Isbister GK, Currie BJ. Suspected snakebite: one year prospective study of emergency department presentations. Emerg Med (Fremantle). 2003;15:160–9.CrossRefGoogle Scholar
  42. Isbister GK, Little M, Cull G, McCoubrie D, Lawton P, Szabo F, Kennedy J, Trethewy C, Luxton G, Brown SG, Currie BJ. Thrombotic microangiopathy from Australian brown snake (Pseudonaja) envenoming. Intern Med J. 2007a;37:523–8.PubMedCrossRefGoogle Scholar
  43. Isbister GK, Duffull SB, Brown SG, Investigators ASP. Failure of antivenom to improve recovery in Australian snakebite coagulopathy. QJM. 2009;102:563–8.PubMedCrossRefGoogle Scholar
  44. Isbister GK, Scorgie FE, O’Leary MA, Seldon M, Brown SG, Lincz LF, Investigators ASP. Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP-10). J Thromb Haemost. 2010;8:2504–13.PubMedCrossRefGoogle Scholar
  45. Isbister GK, O’Leary MA, Elliott M, Brown SG. Tiger snake (Notechis spp.) envenoming: Australian Snakebite Project (ASP-13). Med J Aust. 2012;197:173–7.PubMedCrossRefGoogle Scholar
  46. Isbister GK, Buckley NA, Brown SG. Tiger snake (Notechis spp.) envenoming: Australian Snakebite Project (ASP-13). Med J Aust. 2013a;198:194–5.PubMedCrossRefGoogle Scholar
  47. Isbister GK, Buckley NA, Page CB, Scorgie FE, Lincz LF, Seldon M, Brown SG, Investigators ASP. A randomized controlled trial of fresh frozen plasma for treating venom-induced consumption coagulopathy in cases of Australian snakebite (ASP-18). J Thromb Haemost. 2013b;11:1310–8.PubMedCrossRefGoogle Scholar
  48. Jacoby-Alner TE, Stephens N, Davern KM, Balmer L, Brown SG, Swindells K. Histopathological analysis and in situ localisation of Australian tiger snake venom in two clinically envenomed domestic animals. Toxicon. 2011;58:304–14.PubMedCrossRefGoogle Scholar
  49. Jelinek GA, Smith A, Lynch D, Celenza A, Irving I, Michalopoulos N, Erber W, Joske DJ. The effect of adjunctive fresh frozen plasma administration on coagulation parameters and survival in a canine model of antivenom-treated brown snake envenoming. Anaesth Intensive Care. 2005;33:36–40.PubMedGoogle Scholar
  50. Johnston CI, O’Leary MA, Brown SG, Currie BJ, Halkidis L, Whitaker R, Close B, Isbister GK, Investigators ASP. Death adder envenoming causes neurotoxicity not reversed by antivenom – Australian Snakebite Project (ASP-16). PLoS Negl Trop Dis. 2012;6:e1841.PubMedPubMedCentralCrossRefGoogle Scholar
  51. Johnston CI, Brown SG, O’Leary MA, Currie BJ, Greenberg R, Taylor M, Barnes C, White J, Isbister GK, ASP investigators. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy – Australian Snakebite Project (ASP-19). Clin Toxicol (Phila). 2013;51:417–24.CrossRefGoogle Scholar
  52. Judge P. A case of suspected venom depot syndrome in a dog envenomed by an eastern brown snake (Pseudonaja textilis). Aust Vet Practitioner. 2013;43:475–8.Google Scholar
  53. Judge PR. Coastal taipan (Oxyuranus scutellatus) envenomation of a dog. Aust Vet J. 2015;93:412–6.PubMedCrossRefGoogle Scholar
  54. Kelers K. A study of snake venom detection kit use in dogs and cats. Master of Veterinary Studies thesis, University of Melbourne; 2005.Google Scholar
  55. Kellaway CH. The venom of Notechis Scutatus. Med J Aust. 1929;1:348–58.Google Scholar
  56. Kellaway CH. Observations on the certainly lethal dose of the venom of the black snake (Pseudechis porphyriacus) for the common laboratory animals. Med J Aust. 1930;2:33–41.Google Scholar
  57. King LG, Hendricks JC. Use of positive-pressure ventilation in dogs and cats: 41 cases (1990–1992). J Am Vet Med Assoc. 1994;204:1045–52.PubMedGoogle Scholar
  58. Knochel JP. Rhabdomyolysis and myoglobinuria. Annu Rev Med. 1982;33:435–43.PubMedCrossRefGoogle Scholar
  59. Kuruppu S, Fry BG, Hodgson WC. In vitro neurotoxic and myotoxic effects of the venom from the black whip snake (Demansia papuensis). Clin Exp Pharmacol Physiol. 2006;33:364–8.PubMedCrossRefGoogle Scholar
  60. Lane J, O’Leary MA, Isbister GK. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom. Toxicon. 2011;58:239–46.PubMedCrossRefGoogle Scholar
  61. Lewis PF. Snakebite in animals in Australia. Postgraduate Foundation in Veterinary Science, Sydney, Australia. 1978. p. 287–309.Google Scholar
  62. Lewis PF. The pathology, diagnosis and prophylaxis of tiger snake envenomation in the dog. University of Melbourne; 1984.Google Scholar
  63. Lewis PF. Common tiger snake envenomation in dogs and mice – relationship between the amount of venom injected and the onset of clinical signs. Aust Vet J. 1994a;71:130–2.PubMedCrossRefGoogle Scholar
  64. Lewis PF. Myotoxicity and nephrotoxicity of common tiger snake (Notechis scutatus) venom in the dog. Aust Vet J. 1994b;71:136–9.PubMedCrossRefGoogle Scholar
  65. Lewis PF. Some toxicity thresholds for the clinical effects of common Tiger Snake (Notechis scutatus) envenomation in the dog. Aust Vet J. 1994c;71:133–5.PubMedCrossRefGoogle Scholar
  66. Liu DT, Brown DC, Silverstein DC. Early nutritional support is associated with decreased length of hospitalization in dogs with septic peritonitis: a retrospective study of 45 cases (2000–2009). J Vet Emerg Crit Care. 2012;22:453–9.Google Scholar
  67. Lund HS, Kristiansen V, Eggertsdottir AV, Skancke E, Ranheim B. Adverse reactions to equine-derived F(ab′)2-antivenin in 54 dogs envenomated by Vipera berus berus. J Vet Emerg Crit Care. 2013;23:532–7.Google Scholar
  68. Madaras F, Mirtschin PJ, Kuchel TIM. Antivenom development in Australia. Toxin Rev. 2005;24:79–94.CrossRefGoogle Scholar
  69. Maduwage K, O’Leary MA, Isbister GK. Diagnosis of snake envenomation using a simple phospholipase A2 assay. Sci Rep. 2014;4:4827.PubMedPubMedCentralCrossRefGoogle Scholar
  70. Maduwage KP, Scorgie FE, Lincz LF, O’Leary MA, Isbister GK. Procoagulant snake venoms have differential effects in animal plasmas: implications for antivenom testing in animal models. Thromb Res. 2016;137:174–7.PubMedCrossRefGoogle Scholar
  71. Marshall L. Positive cross reactivity of Bardick Snake (Notechis curtus) venom with death adder (Acanthophis antarcticus) antivenom and negative reactivity with tiger (Notechis scutatus) antivenom. Copeia. 1985;1:257–9.CrossRefGoogle Scholar
  72. Martin C. On some effects upon the blood produced by the injection of the venom of the Australian Black Snake (Pseudechis porphyriacus). J Physiol. 1893;15:380–400.PubMedPubMedCentralCrossRefGoogle Scholar
  73. McMillan MW, Whitaker KE, Hughes D, Brodbelt DC, Boag AK. Effect of body position on the arterial partial pressures of oxygen and carbon dioxide in spontaneously breathing, conscious dogs in an intensive care unit. J Vet Emerg Crit Care. 2009;19:564–70.CrossRefGoogle Scholar
  74. Mebs D, Ehrenfeld M, Samejima Y. Local necrotizing effect of snake venoms on skin and muscle: relationship to serum creatine kinase. Toxicon. 1983;21:393–404.PubMedCrossRefGoogle Scholar
  75. Mirtschin PJ, Masci P, Paton DC, Kuchel T. Snake bites recorded by veterinary practices in Australia. Aust Vet J. 1998;76:195–8.PubMedCrossRefGoogle Scholar
  76. Mohr AJ, Leisewitz AL, Jacobson LS, Steiner JM, Ruaux CG, Williams DA. Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis. J Vet Intern Med. 2003;17:791–8.PubMedCrossRefGoogle Scholar
  77. Moisidis AV, James T, Smith HV, Cox JC. Snake envenomation in cats and its detection by rapid immunoassay. Aust Vet J. 1996;74:143–7.PubMedCrossRefGoogle Scholar
  78. Murray PT, Mehta RL, Shaw A, Ronco C, Endre Z, Kellum JA, Chawla LS, Cruz D, Ince C, Okusa MD, ADQI workgroup. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int. 2014;85:513–21.PubMedCrossRefGoogle Scholar
  79. Nakada F, Uezu N, Ohshiro M, Miyagi K. Relation between serum creatine phosphokinase activity and the amount of habu (Trimeresurus flavoviridis) snake venom injected in thigh muscle in rabbits. Toxicon. 1980;18:351–5.PubMedCrossRefGoogle Scholar
  80. Nakada K, Nakada F, Ito E, Inoue F. Quantification of myonecrosis and comparison of necrotic activity of snake venoms by determination of creatine phosphokinase activity in mice sera. Toxicon. 1984;22:921–30.PubMedCrossRefGoogle Scholar
  81. O’Leary MA, Isbister GK. Commercial monovalent antivenoms in Australia are polyvalent. Toxicon. 2009;54:192–5.PubMedCrossRefGoogle Scholar
  82. Ong RKC, Lenard ZM, Swindells KL, Raisis AL. Extradural haematoma secondary to brown snake (Pseudonaja sp.) envenomation. Aust Vet J. 2009;87:152–6.PubMedCrossRefGoogle Scholar
  83. Ong RKC, Swindells K, Mansfield CS. Prospective determination of the specificity of a commercial snake venom detection kit in urine samples from dogs and cats. Aust Vet J. 2010;88:222–4.PubMedCrossRefGoogle Scholar
  84. Ong HM, Witham A, Kelers K, Boller M. Presumed secondary immune-mediated haemolytic anaemia following elapid snake envenomation and its treatment in four dogs. Aust Vet J. 2015;93:319–26.PubMedCrossRefGoogle Scholar
  85. Ong HM, Kelers K, Hughes D, Boller M. Outcome in cats with elapid snake envenomation associated neurotoxicity requiring mechanical ventilation: 12 cases (2005–2014). J Vet Emerg Crit Care. 2016. Accepted for publication.Google Scholar
  86. Padula AM, Winkel KD. Fatal presumed tiger snake (Notechis scutatus) envenomation in a cat with measurement of venom and antivenom concentration. Toxicon. 2016a;113:7–10.PubMedCrossRefGoogle Scholar
  87. Padula AM, Winkel KD. Red-bellied black snake (Pseudechis porphyriacus) envenomation in the dog: diagnosis and treatment of nine cases. Toxicon. 2016b;117:69–75.PubMedCrossRefGoogle Scholar
  88. Padula AM, Winkel KD. Successful use of camelid (alpaca) antivenom to treat a potentially lethal tiger snake (Notechis scutatus) envenomation in a dog. Toxicon. 2016c;114:59–64.PubMedCrossRefGoogle Scholar
  89. Pang D, Hethey J, Caulkett NA, Duke T. Partial pressure of end-tidal CO2 sampled via an intranasal catheter as a substitute for partial pressure of arterial CO2 in dogs. J Vet Emerg Crit Care. 2007;17:143–8.CrossRefGoogle Scholar
  90. Pascoe R. Brown snake bite in horses in south-eastern Queensland. J S Afr Vet Assoc. 1975;46:129–31.PubMedGoogle Scholar
  91. Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care. 2014;18:224.PubMedPubMedCentralCrossRefGoogle Scholar
  92. Premru V, Kovac J, Ponikvar R. Use of myoglobin as a marker and predictor in myoglobinuric acute kidney injury. Ther Apher Dial. 2013;17:391–5.PubMedCrossRefGoogle Scholar
  93. Preston SA, Davis CE, Harris JB. The assessment of muscle fibre loss after the injection of the venom of Notechis scutatus (Australian tiger snake). Toxicon. 1990;28:201–14.PubMedCrossRefGoogle Scholar
  94. Prittie J, Barton L. Route of nutrient delivery. Clin Techniq Small Animal Pract. 2004;19:6–8.CrossRefGoogle Scholar
  95. Riviere G, Choumet V, Audebert F, Sabouraud A, Debray M, Scherrmann JM, Bon C. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy. J Pharmacol Exp Ther. 1997;281:1–8.PubMedGoogle Scholar
  96. Robertson I, Leggoe M, Dorling P, Shaw S, Clark W. A retrospective study of poisoning cases in dogs and cat: comparisons between a rural and an urban practice. Aust Vet J. 1992a;69:194–5.PubMedCrossRefGoogle Scholar
  97. Robertson ID, Dorling PR, Shaw SE. A prospective study of intoxications in dogs and cats in Western Australia. Aust Vet Pract. 1992b;22:78–85.Google Scholar
  98. Ross L. Acute kidney injury in dogs and cats. Vet Clin North Am Small Anim Pract. 2011;41:1–14.PubMedCrossRefGoogle Scholar
  99. Sharp NJ, Kornegay JN, Bartlett RJ, Hung WY, Dykstra MJ. Notexin-induced muscle injury in the dog. J Neurol Sci. 1993;116:73–81.PubMedCrossRefGoogle Scholar
  100. Shea GM. The distribution and identification of dangerously venomous Australian terrestrial snakes. Aust Vet J. 1999;77:791–8.PubMedCrossRefGoogle Scholar
  101. Steuten J, Winkel K, Carroll T, Williamson NA, Ignjatovic V, Fung K, Purcell AW, Fry BG. The molecular basis of cross-reactivity in the Australian Snake Venom Detection Kit (SVDK). Toxicon. 2007;50:1041–52.PubMedCrossRefGoogle Scholar
  102. Sutherland SK. Treatment of snakebite in Australia and Papua New Guinea. Aust Fam Physician. 1976;5:272–88.PubMedGoogle Scholar
  103. Sutherland SK. Australian venoms, proceedings; 1987a. p. 103.Google Scholar
  104. Sutherland SK. Australian venoms, Veterinary Clinical Toxicology. Post-graduate Committee in Veterinary Sience in association with Chapter of Veterinary Pharmacology, Australian College of Veterinary Science, University of Sydney; 1987b. p. 227–67.Google Scholar
  105. Sutherland SK. Antivenom use in Australia. Premedication, adverse reactions and the use of venom detection kits. Med J Aust. 1992;157:734–9.PubMedGoogle Scholar
  106. Sutherland SK, Best P. Snake envenomation, emergency medicine & critical care. Post-graduate Committee in Veterinary Science, University of Sydney; 1991. p. 167–76.Google Scholar
  107. Sutherland SK, Leonard RL. Snakebite deaths in Australia 1992–1994 and a management update. Med J Aust. 1995;163:616–8.PubMedGoogle Scholar
  108. Swindells KL, Russell NJ, Angles JM, Foster SF. Four cases of snake envenomation responsive to death adder antivenom. Aust Vet J. 2006;84:22–9.PubMedCrossRefGoogle Scholar
  109. Tibballs J. Cardiovascular, coagulation and haematological effects of Brown Snake and Tiger Snake venoms, Department of Pharmacology, Faculty of Medicine, Dentistry and Health Sciences. University of Melbourne; 1998.Google Scholar
  110. Tibballs J, Sutherland SK, Kerr S. Studies on Australian snake venoms, Part II: the haematological effects of brown snake (Pseudonaja) species in the dog. Anaesth Intensive Care. 1991;19:338–42.PubMedGoogle Scholar
  111. Trigg N, McAlees T. Red-bellied black snake (Pseudechius porphyriacus) envenomation in a dog. Aust Vet Practitioner. 2015;45:32–5.Google Scholar
  112. Trigg N, Leister E, Whitney J, McAlees T. Outcomes of mechanical ventilation in 302 dogs and cats in Australia (2005–2013). Aust Vet Practitioner. 2014;44:698–703.Google Scholar
  113. Valentine BA, Blue JT, Shelley SM, Cooper BJ. Increased serum alanine aminotransferase activity associated with muscle necrosis in the dog. J vet Inter Med Am College Vet Inter Med. 1990;4:140–3.CrossRefGoogle Scholar
  114. Webster RA, Mills PC, Morton JM. Indications, durations and outcomes of mechanical ventilation in dogs and cats with tick paralysis caused by Ixodes holocyclus: 61 cases (2008–2011). Aust Vet J. 2013;91:233–9.PubMedCrossRefGoogle Scholar
  115. White J. Envenoming and antivenom use in Australia. Toxicon. 1998;36:1483–92.PubMedCrossRefGoogle Scholar
  116. White J. Snake venoms and coagulopathy. Toxicon. 2005;45:951–67.PubMedCrossRefGoogle Scholar
  117. Wiener S. Active immunization of man against the venom of the Australian tiger snake (Notechis scutatus). Am J Trop Med Hyg. 1960;9:284–92.PubMedCrossRefGoogle Scholar
  118. Witsil AJ, Wells RJ, Woods C, Rao S. 272 cases of rattlesnake envenomation in dogs: demographics and treatment including safety of F(ab′)2 antivenom use in 236 patients. Toxicon. 2015;105:19–26.PubMedCrossRefGoogle Scholar
  119. Woods C, Young D. Clinical safety evaluation of F(ab′)(2) antivenom (Crotalus durissus-Bothrops asper) administration in dogs. J Vet Emerg Crit Care. 2011;21:565–9.CrossRefGoogle Scholar
  120. Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJ, de Visser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord. 2014;24:651–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Australian Venom Research Unit, Department of Pharmacology and Therapeutics, Faculty of MedicineUniversity of MelbourneParkville, MelbourneAustralia
  2. 2.Emergency and Critical Care, UVet Werribee Animal HospitalUniversity of MelbourneMelbourneAustralia

Personalised recommendations